fashion -WSS

fashion

author：leisure time 2025-09-27 12:22:27 - browse：9451

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： FDA has safety concerns on CRISPR

hotspot

explore

WSS

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Testing for cancer recurrence creates a new limbo for patients

What to know about Virgin Galactic's 1st mission taking paying customers to space

Biden's order seeks to regulate AI risk without stifling innovation

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

In same hospitals, Black patients receive fewer opioids than white patients

hotspot

fashion

The need-to-know this morning

Is it time to worry about Moderna?

entertainment

BioMarin wins approval for gene therapy to treat hemophilia A

The pink breast cancer awareness ribbon needs a redesign

Duchenne breakthrough therapy leaves behind pioneering families

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Testing for cancer recurrence creates a new limbo for patients

ChatGPT in medicine: STAT answers readers' burning questions

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Walensky prepares to leave CDC — and Congress — behind

Chimpanzees, like humans and whales, get menopause: Study

leisure time

Physician subsidies by hospitals soar in wake of No Surprises Act

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Medtronic CEO on promising devices for diabetes, hypertension

hotspot

focus

explore

hotspot